Pomalidomide
NICE TA338 - Do not recommend. Relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib
- Traffic LightGrey
- BNF8.2.4
- Licensed Indicators
- ReferenceAPC Apr 15
- Criteria
- ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?